In vivo, coinjection of miR‐193a‐3p‐knockdown CAFs with KYSE150 ESCC cells resulted in smaller tumours, fewer lung metastases, increased PTEN and E‐cadherin, and decreased p‐Akt and Snail expression. The gene discussed is AKT1; the disease is esophageal squamous cell carcinoma.